HA-Arqam-Yousuf-header-620x400

WFH Humanitarian Aid Program: 16-year-old able to undergo surgery

Arqam Yousuf is a 16-year-old boy from Rawalpindi, Pakistan. He has severe Hemophilia B, and he was recently diagnosed with appendicitis. His physician determined that he would require an appendectomy—a procedure that is relatively routine for people without hemophilia and without any other comorbidities.

Also available in: Français Español

Arqam Yousuf is a 16-year-old boy from Rawalpindi, Pakistan. He has severe Hemophilia B, and he was recently diagnosed with appendicitis. His physician determined that he would require an appendectomy—a procedure that is relatively routine for people without hemophilia and without any other comorbidities. For Arqam, however, undergoing the procedure without clotting factor concentrates (CFCs) or some kind of hemophilia medication would be fatal. The WFH Humanitarian Aid Program exists for people like Arqam. In 2020, the Program donated over 5.5 million IUs of factor concentrates, and over 100,000 mg of non-factor replacement therapy to Pakistan. Arqam received donated extended half-life factor IX from the Program, and this donation made it possible for him to not only undergo the appendectomy—but also to make a full recovery.

The WFH Humanitarian Aid Program has been very active in Pakistan, and has provided over 40 million IUs of donated factor to hemophilia treatment centres (HTCs) in the country since 2005. To find out more about the WFH Humanitarian Aid Program, click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and our Contributors, CSL Behring and Takeda.  To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.